SCIACOVELLI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.041
AS - Asia 3.138
EU - Europa 2.417
AF - Africa 650
SA - Sud America 622
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 25
Totale 12.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.701
IT - Italia 1.089
SG - Singapore 1.065
CN - Cina 577
BR - Brasile 392
VN - Vietnam 348
HK - Hong Kong 285
PL - Polonia 173
FR - Francia 138
DE - Germania 105
FI - Finlandia 104
IN - India 99
SE - Svezia 99
RU - Federazione Russa 87
NL - Olanda 77
GB - Regno Unito 69
JP - Giappone 55
AR - Argentina 53
CA - Canada 49
ID - Indonesia 49
IQ - Iraq 48
TR - Turchia 39
UA - Ucraina 39
MX - Messico 38
BD - Bangladesh 37
EC - Ecuador 35
ZA - Sudafrica 35
PH - Filippine 34
ES - Italia 33
SA - Arabia Saudita 31
TN - Tunisia 31
EG - Egitto 29
PK - Pakistan 29
MU - Mauritius 28
MA - Marocco 26
UZ - Uzbekistan 26
ET - Etiopia 24
PT - Portogallo 24
VE - Venezuela 24
PS - Palestinian Territory 23
RO - Romania 23
AZ - Azerbaigian 22
CI - Costa d'Avorio 22
GR - Grecia 22
NI - Nicaragua 22
AE - Emirati Arabi Uniti 21
AT - Austria 21
CO - Colombia 21
PE - Perù 21
AO - Angola 20
KR - Corea 20
LC - Santa Lucia 20
CG - Congo 19
HU - Ungheria 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
MY - Malesia 19
NP - Nepal 19
TH - Thailandia 19
BF - Burkina Faso 18
CL - Cile 18
DZ - Algeria 18
GT - Guatemala 18
IE - Irlanda 18
KE - Kenya 18
LB - Libano 18
NO - Norvegia 18
PY - Paraguay 18
UG - Uganda 18
YE - Yemen 18
CU - Cuba 17
DO - Repubblica Dominicana 17
GN - Guinea 17
KG - Kirghizistan 17
KZ - Kazakistan 17
MG - Madagascar 17
PA - Panama 17
TJ - Tagikistan 17
TZ - Tanzania 17
ZW - Zimbabwe 17
AL - Albania 16
BA - Bosnia-Erzegovina 16
GE - Georgia 16
LU - Lussemburgo 16
LY - Libia 16
ME - Montenegro 16
RW - Ruanda 16
UY - Uruguay 16
BJ - Benin 15
CH - Svizzera 15
IS - Islanda 15
KH - Cambogia 15
NC - Nuova Caledonia 15
SK - Slovacchia (Repubblica Slovacca) 15
TW - Taiwan 15
ZM - Zambia 15
AM - Armenia 14
BE - Belgio 14
BS - Bahamas 14
BZ - Belize 14
Totale 12.307
Salva come PNG Salva come JPEG
Città #
Fairfield 796
Ashburn 669
Singapore 667
San Jose 567
Woodbridge 484
Houston 345
Ann Arbor 292
Cambridge 291
Chandler 270
Seattle 269
Hong Kong 260
Wilmington 248
Bytom 141
Ho Chi Minh City 112
Beijing 108
Boardman 96
Santa Clara 93
Milan 92
Princeton 92
Hanoi 88
San Diego 80
Los Angeles 71
Lauterbourg 65
Medford 64
Rome 59
Helsinki 58
Padova 45
Nanjing 43
Des Moines 42
Roxbury 41
Jacksonville 40
São Paulo 35
Tokyo 30
New York 29
Chicago 27
Florence 27
Tashkent 24
Trento 24
Bologna 23
Baku 22
Managua 21
Abidjan 20
Castries 20
Frankfurt am Main 20
Jinan 20
Buffalo 18
Dallas 18
Haiphong 18
London 18
Munich 18
Vientiane 18
Conakry 17
Hebei 17
Kampala 17
Antananarivo 16
Council Bluffs 16
Guangzhou 16
Harare 16
Kigali 16
Montevideo 16
Nairobi 16
Naples 16
Panama City 16
Shenyang 16
Ulan Bator 16
Baghdad 15
Da Nang 15
Dar es Salaam 15
Genoa 15
Havana 15
Johannesburg 15
Montreal 15
Nanchang 15
Noumea 15
Dong Ket 14
Dublin 14
Luanda 14
Lusaka 14
Ouagadougou 14
Warsaw 14
Amman 13
Bishkek 13
Cotonou 13
Dakar 13
Dushanbe 13
Luxembourg 13
Nassau 13
Phnom Penh 13
Shanghai 13
Addis Ababa 12
Brasília 12
Kingstown 12
Niamey 12
Rio de Janeiro 12
San José 12
Shenzhen 12
Tbilisi 12
Venezia 12
Bamako 11
Bridgetown 11
Totale 7.731
Salva come PNG Salva come JPEG
Nome #
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 647
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 616
What information on measurement uncertainty should be communicated to clinicians, and how? 244
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 235
Harmonization of pre-analytical quality indicators. 233
Quality indicators to detect pre-analytical errors in laboratory testing 231
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 220
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 219
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 216
Performance criteria and quality indicators for the pre-analytical phase. 214
Decision Support and Patient Safety 208
Assessment of package inserts for diagnostic kits. 201
An integrated system for monitoring the quality of sample transportation. 199
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 198
An Italian External Quality Assessment (EQA) program on urinary sediment. 197
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 197
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 195
Extra-analytical sources of uncertainty: which ones really matter? 194
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 192
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 189
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 188
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 187
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 187
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 187
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 184
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 182
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 174
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 173
Reference intervals: Are interlaboratory differences appropriate? 170
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 170
Once upon a time: A tale of ISO 15189 accreditation 170
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 170
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 169
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 169
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 167
Performance specifications of critical results management 165
Quality indicators for laboratory diagnostics: consensus is needed. 162
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 157
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 156
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 155
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 154
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 154
Measurement uncertainty: Light in the shadows 154
Effects of sample transportation on commonly requested laboratory tests. 153
Risk management in laboratory medicine: quality assurance programs and professional competence. 152
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 152
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 151
External quality assessment programs in the context of ISO 15189 accreditation 151
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 149
External Quality Assessment Schemes: need for recognised requirements 149
Preanalytical challenges - time for solutions 149
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 147
The silk road to total quality in Laboratory Medicine 146
Quality specifications in EQA schemes: from theory to practice 143
Extra-analytical quality indicators and laboratory performances 141
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 138
Extra-analytical quality indicators - Where to now? 138
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 137
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 136
Importance of control materials in quality assessment of cyclosporine determination. 134
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 133
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 133
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 132
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 131
Post-standardization of routine creatinine assays: are they suitable for clinical applications 130
Critical laboratory results: communication is just one of the problems. 128
Quality Indicators for the Total Testing Process 117
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 110
IFCC project “Model of quality indicators”: a method for results evaluation 103
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 102
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 98
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 97
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 96
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 95
Totale 13.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.081
article - articoli 32.365
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 0 0 0 0 0 82 156
2021/20221.067 57 101 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20265.991 227 564 938 1.123 569 229 631 574 619 417 100 0
Totale 13.020